ANXA11 and cancer: Species and/or cancer-subtype specific differences may exist, as ANXA11 downregulation in the murine Hca-P hepatocarcinoma cell line promoted in vivo tumour growth, lymph node metastatic potential and chemoresistance towards 5-fluorouracil [422].